>>So 227,272 should expect to go from 20/400 to 20/40. Thats without refined injections and some with bettor vision.<<
Agree. Even though we have on record, a patient dramatically going from 20/400 to 20/40 vision , that is not to say this was the "only" improvement in eyesight witnessed. Even lesser improvement in other patients would be seriously successful news. Improvement or even HALTING of sight deteriation for these deseases is MAJOR news. By allowing treatment earlier in the diagnosis of the desease, before serious sight loss, and halting or slowing the progression of the desease, would be a very successful accomplishment since there is NO other comparable treatment for said deseases. Therefore, that is why I feel it is very noteworthy that the trials have been adjusted to allow for less serious patients to recieve cell implantation. Dont forget we are early in these trials with what is still low dosage of cells at this stage. Hopefully with results, we will see higher dosages and more significant results. Remember Phase I is primarily for safety, so caution was practiced with low dosage and more severely afflicted patients. With safety all but comfirmed, certain restrictions should be lifted to hopefully reveal more favorable results with those less afflicted.
